Erratum: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (Eur J Nucl Med Mol Imaging DOI 10.1007/s00259-012-2330-6)

2014-03-01

Additional Metadata
Persistent URL	doi.org/10.1007/s00259-013-2454-3, hdl.handle.net/1765/53460
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Organisation	Department of Nuclear Medicine
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Bodei, L., Mueller-Brand, J., Baüm, R., Pavel, M., Hörsch, D., O'Dorisio, M., O'Dorisio, T., Howe, J., Cremonesi, M., Kwekkeboom, D. J.& Zaknun, J. (2014). Erratum: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (Eur J Nucl Med Mol Imaging DOI 10.1007/s00259-012-2330-6). European Journal of Nuclear Medicine and Molecular Imaging, 41(3).https://doi.org/10.1007/s00259-013-2454-3

Publication